Hill's has launched 'Lose 60 Tonnes in 6 months', a campaign to help clients get their pet to a healthy weight.
Sixty tonnes is equivalent to the weight of twelve elephants, which is a huge target. Hill's says that if every practice makes a small contribution, it can be achieved.
Hill's support includes a public relations pack which the company says contains everything veterinary surgeons and nurses need to help raise awareness and encourage pet owners to bring their pets in for a weight assessment. The pack includes proforma press releases and guidance on how to cultivate a mutually beneficial relationship with local media. There is also a 'Lose 60 tonnes in 6 months' point of sale kit that includes a poster, stickers and a noticeboard kit for clinics, to drive awareness while clients wait for consults.
As part of the campaign, Hill's is also hosting a series of nurse webinars on weight management and offering additional support material such as consult room posters, weight clinic packs and pet tape measures, an item often requested by nurses. There are also promotional offers available through Hill's Territory Managers, subject to stock availability.
Hill's Customer Marketing Manager, Sara Locke MRCVS said: "We feel it is important to support practices at the grass-roots level and to develop a campaign that will have real meaning within the local community. I hope practices will get behind it, engage with pet owners and as a result, gain new clients. They are also helping thousands of pets live longer and happier lives."
Further information is available from local Hill's Territory Managers or by calling Hill's on 0800 242438 or in ROI 1 800 626002.
A research project funded by equine charity The Horse Trust has found that lameness is the most common reason for euthanasing a geriatric horse.
According to the charity, this research is the first in the UK to provide data on the causes of death in geriatric horses. Although post-mortem studies have provided some data regarding causes of death, "old age" was previously reported as a common reason for the euthanasia of adult horses.
The research was carried out by Joanne Ireland at the University of Liverpool and led by Dr Gina Pinchbeck. Ireland surveyed horse owners living in the North-West and Midlands areas of England and North Wales who have a horse aged 15 years or older. 918 owners of geriatric horses were followed in a cohort study and 118 mortalities were reported during the 18 month follow-up period, of which 111 were euthanased.
The researchers found that 24% of horses were euthanased due to lameness; an additional 12% were euthanased due to laminitis - a common cause of lameness. After lameness, colic was the next most common cause of euthanasia, with 21% of owners citing this as the main reason.
In an earlier stage of the project, the researchers had found that half the geriatric horses surveyed suffered from lameness, but only 24% of owners reported the problem.
Dr Pinchbeck said: "Although lameness is common in older horses, this is the first study to quantify its contribution to their mortality.
"Owners are often missing the early signs of lameness in their horse, which means the condition isn't being managed and may deteriorate faster."
Dr Pinchbeck said it would be useful to carry out further research into lameness in geriatric horses to find out the main causes of lameness and how these may be prevented or treated.
The research team also found that half of the horses euthanased were suffering from concurrent health problems and these influenced the owner's decision to euthanase in 43% of cases. The most frequently reported additional health problems were musculoskeletal problems, such as arthritis.
The mortality rate among the horses surveyed was 11 per 100 horse-years at risk, meaning that if 100 geriatric horses were followed for a year, an average of 11 would die. The mortality rate for horses over 30 years of age was over five times the rate than in horses aged 15 - 19 years.
Jeanette Allen, Chief Executive of The Horse Trust, said the data provided by this research is likely to provide useful information for both horse owners and vets to enable them to improve the welfare of older horses. She said: "As there are a significant number of geriatric horses in the UK, it is vital that we understand more about the health problems that affect them. We hope that more owners of older horses will give their horse an annual health-check to enable the horse to have a longer, healthier life."
The research was published in the September 2011 issue of Preventive Veterinary Medicine.
Vetoquinol has announced the launch of Equistro Flexadin UCII, an equine joint supplement.
Equistro Flexadin UCII contains a new ingredient, UC-II, which the company claims is one of the most effective and influential ingredients available that aids and supports healthy joint function.
To celebrate the launch of Flexadin UCII Vetoquinol is offering a £10 money off voucher available through purchases of Horse & Hound magazine starting from November 10th.
Caitríona Mullin, Equine Product Manager at Vetoquinol UK Ltd said: "We are very excited about the launch of Flexadin UCII in the UK and Ireland, we have already received excellent feedback from our German and French colleagues. Flexadin UCII is a product that will further enhance our premium range of equine supplements formulated specifically for the performance horse."
Becky Hussey has been announced as the winner of the 2011 Royal Canin Pet Health Counsellor of the Year Award. Second prize was awarded to Sian Ferris from The Smart Clinic in Cardiff and third place to Lana Goulding of Claremont Vet Group, Bexhill-on-Sea.
The PHC of the Year scheme has been running for over sixteen years and this year saw a record number of entrants for judge and well-known pet behaviourist Sarah Heath, BVSc, MRCVS, to assess. As part of the initiative, participants receive specialist training of a wide variety of topics, highly relevant to veterinary nurses' growing involvement in veterinary practice. The original aim of the PHC programme was to help veterinary nurses to improve their knowledge and skills to enable them to be even more confident when advising clients and developing clinics. Whilst this aim still holds true, a veterinary nurse achieving PHC status is now widely recognised as a valuable asset to a practice, as well as significantly enhancing personal development.
Becky's entry this year detailed the many activities she undertakes, in addition to her daily duties, at the practice where she works. They included various client pet clinics, a "Choose a pet" advice service, client competitions, numerous advertorials to help raise the practice group's profile and lots of charity fund-raising. She was also part of the team whose hard work resulted in the practice being granted RCVS Accreditation.
Pet owners who believe in preventative healthcare have maintained or increased the money they spend on their pets this year, and 84% visited their vet at least once in 2010, up from 78% in 2007, according to a survey commissioned by the National Office of Animal Health.
According to the survey of 1000 owners carried out by Noesis, 44% of 'preventers' increased their spending on their pets in the last year with only a very small number (5%) decreasing it. There has also been a significant increase in the number of dogs insured by this group since 2007, which now stands at 55% compared to 41% in 2007.
The research covered both 'preventer' and 'non-preventer pet owners and sought to understand: awareness of preventative medicine in cats and dogs; how the decision is made as to what areas of preventative medicine are important and which to adopt; what types of preventative medicine are carried out and the reasons and frequency of this behaviour as well as the sources of information.
In addition to visiting their vet more frequently and spending more on their pets, preventers also visited a pet shop significantly more often than non-preventers with nearly two thirds (61%) of preventers visiting at least once a month compared to 36% of non-preventers, a figure that has decreased from 43% in 2007.
Looking at specific preventative treatments, attitudes to vaccination had not changed between the 2007 and 2010 surveys, with preventers believing that being a responsible pet owner means regularly vaccinating your pet, while non-preventers did not believe vaccination was relevant to their situation. This points to a clear need to educate non-preventers to break habits that have sometimes been handed down from generation to generation.
Most owners from both groups had used a flea treatment on their pets in the past two years although 68% of preventers were much more proactive in their usage of flea products compared to only 40% of non-preventers. Cats (80%) are more likely to have been treated than dogs (69%) among both groups of owners although flea treatment of cats has significantly decreased among non-preventers since 2007.
Use of wormers was also in decline. Although 86% of preventers worm proactively as part of a healthcare routine for their pet, this figure has decreased from 96% in 2007. Non preventers chose not to worm because they did not see the need, citing reasons such as their pet being fit and well or not going outdoors. Likewise, although preventers are more likely than non-preventers to be aware of the zoonotic implications of pet parasites, this awareness had decreased since 2007 pointing to the need for more work to be done on this aspect of pet health. On a more upbeat note, those that were worming proactively wormed their pets more frequently with 50% worming at least every three months in 2010 which was significantly more than compared to 41% in 2007.
When asked where they obtained general healthcare advice, the vet was the most frequently cited source of information with 84% of preventers and 58% of non-preventers referencing their vet. The internet is an increasingly important information channel for non-preventers with almost a third (31%) citing it as their source for pet healthcare advice, an increase from 25% in 2007.
There was huge interest from both groups (87% of preventers and 79% of non-preventers) in using a dedicated website such as NOAH's http://www.pethealthinfo.org.uk/ which 10% of the pet owners surveyed had heard of. It was welcomed for providing easy access, immediate, independent advice and being written by veterinary experts.
Commenting on the research, Phil Sketchley, chief executive of NOAH said: "We commissioned the original piece of research in 2007 to understand the differences between both groups of pet owners and understand where they sourced their information in order to influence the pet healthcare habits of the non-preventers in particular. The importance of the internet as a source of information proved that our strategy to launch http://www.pethealthinfo.org.uk/ was on target and the latest survey shows that this channel is increasingly important, particularly among non-preventers.
"The 2011 survey also reveals some positive insights into the preventative healthcare habits of those pet owners that we termed preventers. This group are more likely to insure their pet (45% vs 12%), go to the vet at least once a year (84% vs 30%) and visit a pet shop at least on a monthly basis (61% vs 36%). And, as a final piece of good news, this group have increased their total spend on their pets in the last year and very few members of either group had decreased their spend.
"Whilst all pet owners consider themselves responsible clearly some do not see regular preventative healthcare as part of that responsibility. So there remains a clear need to educate pet owners, particularly the non-preventers, to change some of the patterns of behaviour and complacency regarding their pet's health that have become entrenched and seem to have been influenced by friends and family."
According to a survey carried out by Pfizer, veterinary surgeons are generally upbeat about the business prospects for their practice this year, despite predicting a harsh economic environment for the industry as a whole in 2011.
The Pulse Survey of more than 400 practice owners and their senior management teams, which presents a snapshot of market sentiment, revealed that predictions for the veterinary market in general remained as gloomy as 2010. Over half (52%) of respondents believed that conditions for the industry would get more challenging.
However, the response from owners about their own practice's performance was more bullish with a third (34%) believing their prospects will improve.
Pfizer Business Consultant, James White, said: "Practices are right to remain cautiously optimistic about 2011 if we accept it's going to be a challenging year. Some practices came slightly unstuck in 2010 as a result of the knock-on effects of the economic downturn on pet owners' pockets. However, by implementing the correct strategies now there are still opportunities for growth. Client loyalty is the buzz word and should remain a key component of any practice strategy being implemented in the coming months."
Pfizer launched the Pulse survey in Autumn 2010 to deliver up to date analysis on a range of issues that senior management teams at practice level are witnessing. According to the company, the survey is attracting a growing volume of respondents. All participants receive a summary report of the Pulse Survey findings.
Pfizer's team of Business Consultants is working with practices throughout the country to pinpoint their individual business challenges, offer solutions through the company's Vet Support+ service and work with the practices to drive growth. For further information visit http://www.vetsupportplus.co.uk/.
Supreme Petfoods has launched the VetCarePlus range of Monoforage® diets for rabbits.
According to the company, the new range represents an entirely new generation of rabbit food, made possible because of a breakthrough in production technology.
The big advance is the level of fibre within a mono-component style diet: 28%-34% across the range, along with the inclusion - uniquely - of essential long fibre particles. Supreme says the result is a less dense food that is beneficial for a rabbit's sensitive digestion system, with the added benefit of extending the feeding time, which is good for dental wear.
The company also says VetCarePlus performs exceptionally well in palatability tests and that it's been widely welcomed throughout the rabbit welfare community. Molly Varga BVetMed DZooMed MRCVS said: "This is exactly what convalescing rabbits need, an excellent level of fibre with no chance of selective feeding plus a good slow chew rate".
The range comprises three specific formulas for Weight Management, Urinary Tract Health and Digestive Health.
Supreme says feedback on samples sent to welfare organisations, veterinary schools and practicing vets so far has been very positive. Vets are delighted with the simplicity of the products, and have welcomed the way Monoforage encapsulates all the benefits of hay, with minimal processing compared to other diets.
Molly Varga added: "All the benefits of hay are preserved while this diet gives more volume of fibre per measurement of food than I have seen before, without increasing the weight (and therefore energy) components". VetCarePlus delivers the maximum possible crude fibre and long fibre content available to date.
Claire Hamblion, Marketing Manager for VetCarePlus said: "Supreme Petfoods feels that VetCarePlus is pushing forward the boundaries on specialist diets for rabbits. Monoforage provides completely unique levels of fibre and we're delighted that all the feedback we have received from a wide range of experts has been exceptionally enthusiastic and welcoming".
For more information on how to stock VetCarePlus products contact Supreme Petfoods at sales@supremepetfoods.com or visit http://www.supremeprofessional.com/
Ceva Animal Health UK has announced that following the success of it's TV advertising campaign for Feliway earlier this year, which boosted sales by 30%, it'll be running the Feliway campaign again, throughout July.
Featuring 'That Purple Cat', who is liked by over 2,300 people on Facebook, Ceva says the campaign will help raise awareness of the signs of behavioural issues in cats, such as vertical scratching, and highlight the benefits of using the pheromone. The advertisement will target Feliway's key audience and will be seen by over 5 million people when it appears on channels such as Dave, E4, Gold, More4 and Yesterday.
For further information or to view the TV advertising campaign, visit www.secrettohappypets.com.
In a statement given to the Veterinary Record earlier this year, the College said:
"In 2017, our commitment to equality for our LGBTQ+ employees, members of the professions and other stakeholders, was cemented when we became a Stonewall Diversity Champion, with the aim of ensuring that all people in the community are accepted, without exception, within the veterinary professions.
In subsequent years this commitment has been demonstrated by the establishment of our Diversity & Inclusion Group, for which LGBTQ+ representation is a key component and has been incorporated into both our internal and external diversity and inclusion strategies.
Focusing on our internal diversity and inclusion strategy, the insight from Stonewall and our internal LGBTQ+ group, has aimed to make the RCVS a safe space for people from the LGBTQ+ community by creating a fully inclusive workplace.
These insights have also fed into the profession-facing work of the Diversity & Inclusion Group and its strategy.
After six years as a Stonewall Diversity Champion, we have decided this year not to renew our contract with the organisation, on the basis that we feel we no longer need to work with an external organisation to continue to deliver on our commitment to equality, diversity and inclusion.
The RCVS will continue to demonstrate allyship and be a safe space for all groups within the LGBTQ+ community, as demonstrated by the fact we are creating a staff network representing RCVS colleagues from marginalised communities.
We may in future decide to work with another accredited organisation, but until the staff network is in place, no decisions have been made. For example, we have recently brought in a staff policy regarding how best to support RCVS employees who are going through the process of gender reassignment, reiterating the current legal position, how to report experiencing or witnessing transphobic discrimination, as well as advice for colleagues supporting those undergoing gender reassignment and those who have family members going through the process. We are grateful for Stonewall for working with us over the past six years and helping us, through its Workplace Equality Index, to finesse our policies and procedures in relation to LGBTQ+ rights and issues and drive forward our agenda to be a diverse and inclusive workplace and regulator."
The National Office of Animal Health has completed its annual review of its Code of Practice for the Promotion of Animal Medicines, and a number of changes will come into effect on 1st July 2011.
One change spells out the way antimicrobial medicines are promoted to farmers, with a firm emphasis on correct use and education.
Advertisers will be required to describe the condition the product is aiming to treat, and to promote an understanding of the treatment of the disease.
The phrase "use medicines responsibly" will always be included in text, making the voluntary strapline introduced in 2009 a formal part of the NOAH Code. As with all promotions to people other than prescribers, farmers will always be reminded to consult their veterinary surgeon.
Advertising text will always state clearly the name of the company and the brand being promoted, and promotion must not be designed to disguise its real nature.
Withdrawal periods for products will be stated, but these must not be unduly prominent and not in a font size greater than the body copy containing recommended dosage and species description.
The changes were proposed by NOAH within its formal response to the Veterinary Medicines Directorate's consultation on the Veterinary Medicines Regulation 2010. The Minister decided in December 2010 to continue to allow the advertising of antimicrobial veterinary products to farmers.
Phil Sketchley, NOAH Chief Executive, said: "Whilst welcoming the Government's decision in December not to further restrict the advertising of animal medicines, we feel that the industry should take a proactive role to ensure the system works properly. We believe it is important for farmers, who are legally responsible for the health and welfare of their animals and the food produced from them, to be aware of the medicines that are available to protect the health of their animals, and at the same time we want them to know that these medicines must be prescribed and used responsibly.
"The issue of antimicrobial resistance is one that affects us all. The way to promote best practice is through education by maintaining all lines of communication between farmers, vets, scientists and animal medicine producers.
"Antibiotics are essential for maintaining the health and welfare of all animals, but like any medicine they need to be used responsibly in order to maintain their effectiveness, and their availability for future generations."
Royal Canin is to launch a hepatic diet for cats.
Available from July 2011, Royal Canin Hepatic Feline is designed to provide nutritional support to the cat post-surgery and throughout a wide range of clinical conditions including cholangitis, cholestasis, portosystemic shunts, hepatic encephalopathy, liver failure and hepatic copper accumulation.
Royal Canin says the diet includes the use of highly digestible vegetable proteins which reduce the workload of the recovering liver; low copper levels to help reduce the risk to the liver of damage caused by copper and bile interaction; an exclusive antioxidant complex to neutralise free radicals, and balanced mineral levels to help counteract electrolyte imbalances caused by liver disease.
The company also says Royal Canin Hepatic Feline is 'outstandingly palatable', making it much easier for the cat (and the owner) to adhere to the regime.
Royal Canin Hepatic Canine is also available in both wet and dry versions. For more information, contact your Royal Canin Veterinary Business Manager, call 0845 717 800, or visit http://www.royalcanin.co.uk/.
Novartis Animal Health has launched its Summer Worming Packs.
The packs are part of an ongoing campaign by the company to get pet owners to worm their animals at least 4 times a year (as recommended by the European Scientific Counsel Companion Animal Parasites1), as opposed to the current norm of 2.6 times per year2.
The Summer Worming Packs include waiting room and client materials, and practice PR support materials. There is also a pet owner website http://www.wormpatrol.co.uk/.
For further details about the Summer Worming Pack or the Worm Patrol Campaign, veterinary practices should contact their Novartis Animal Health Territory Manager.
CVS says the use of ear cytology in OE is beneficial, both as a diagnostic and to evaluate the response to therapy.
However, in 2019 the company looked at 26,269 of its patients and found that ear cytology was only being used in 19.2% of cases, in line with the rest of the profession.
Only 11% of cases were being provided with in-house point-of-care cytology, whilst 8.2% had it performed externally.
80.8% of patients with OE were being prescribed antibiotics without cytological support, with 5% of these the highest priority critically important antibiotics (HPCIAs).
This low level of cytology use in primary care was suspected to be a major contributory factor to the significant use of unnecessary antibiotics.
To support its practices, CVS first looked at the barriers to performing ear cytology interventions, which were identified as a lack of confidence in using the microscope (particularly focusing on x100 and identification of pathological events), a perceived lack of time, insufficient or poorly working equipment, a lack of access to equipment, and the perception that cytology does not change the treatment choice or outcome.
As a second step, a minimal list of cytology equipment was developed to ensure that all sites had the right kit.
New equipment was then supplied to a practice if it did not meet minimum standards.
The company then produced education and resource materials, including new guidelines, imagery and video guides, to upskill both its vets and nurses.
The training focused on: equipment maintenance, cleaning and troubleshooting, how to use the microscope – including x100 magnification and the slide oil immersion technique, how to identify pathological changes, and time management to get a consultation done – including swabbing, microscope analysis, diagnosis and client consultation.
Each site was then provided with its own data, so that it could monitor progress.
Elizabeth McLennan Green, CVS Clinical Director for the North, said: “One of our goals with this project was to minimise the number of antibiotics prescribed without associated diagnostics, and to use ear cytology to guide therapy and response to treatment for the benefit of our patients and clients.”
“We know that low ear cytology interventions are an issue across the profession. We wanted to do better. So ear cytology has been our first and longest running clinical improvement project.
"We’re thrilled with the brilliant results our colleagues are now achieving.”
There's a video presentation about the project here: https://vimeo.com/875515008/bdc3ee5920
Photo: Emily Spencer, Head Vet at Castle Vets
Dr Kalisz faced a total of nine charges (including 41 sub-charges).
The first was that in July 2020, she failed to carry out a clinical examination of the dog, failed to adequately interpret test results, failed to ask for help interpreting the results, and undertook an emergency Caesarean section without sufficient need to do so.
The other charges related to undertaking a colotomy without sufficient justification and without exercising sufficient clinical judgment throughout the procedure.
For both the Caesarean section and the colotomy, Dr Kalisz faced charges that she failed to obtain informed consent from the owners and failed to inform them that the colotomy had been carried out, or of the potential risks of the procedure, and also failed to provide enough information about aftercare.
It was also alleged that Dr Kalisz had demonstrated continual lapses in professional judgement, including failing to appropriately manage the spaniel’s worsening condition when it was presented to the practice again later, and that the clinical records in relation to the surgery were dishonest and/or misleading.
Dr Kalisz admitted serious professional misconduct, admitting to 29 of the sub-charges, while the remaining 12 sub-charges were denied.
The Committee found 30 of the sub-charges proven, with the remaining 11 not proven.
The Committee the considered aggravating factors, including the fact that Dr Kalisz's conduct led to the spaniel’s death, the colotomy was reckless and Dr Kalisz did not take steps to inform anybody or make a clinical record for the colotomy.
In mitigation, the Committee considered the fact that it was single and isolated incident (albeit one that spanned a number of days), that no other members of the clinical team involved raised concerns during the procedure, and the effect Covid had upon the veterinary profession.
The Committee found that of those charges proven, the ones relating to performing the colotomy, failing to manage the spaniel’s subsequent care and failing to mention the colotomy amounted to serious professional misconduct.
On deciding the sanction, the Committee took into account the mitigation submitted on behalf of Dr Kalisz and the written testimonials produced including the fact that she was young and inexperienced, had admitted her failings at an early stage, had made subsequent efforts to avoid a repetition of such behaviour and that a significant amount of time had passed since the incident.
The Committee also considered that Dr Kalisz had shown an exemplary level of insight, showing remorse for her actions, undertaking substantial continuing professional development, and finding appropriate ongoing professional mentorship.
The Committee was impressed by the character testimonials from veterinary co-workers, both current and at the time of these events, as well as from clients.
It was, the Committee said, apparent from those testimonials that Dr Kalisz had been open and honest with them about the charges and was considered to be an excellent, committed veterinary surgeon.
Paul Morris, chairing the Committee and speaking on its behalf said: “The Committee found that this was a single isolated incident, which involved serious lapses of clinical judgement.
"It was therefore concluded that, despite Dr Kalisz’s actions being reckless, the extensive mitigation and the high level of insight, coupled with steps taken to avoid repetition, meant that there was negligible future risk to animal welfare.
“The Committee did not consider it necessary to issue a warning to Dr Kalisz about her future conduct, on the basis that the Committee has concluded that there is little risk of repetition, so considered that a reprimand would be an appropriate sanction in this case.”
https://www.rcvs.org.uk/concerns/disciplinary-hearings
Vetoquinol UK Ltd is launching a dedicated large animal/equine sales force on the 1st July.
The company says the move reflects the change in cattle and equine veterinary practice to become specialists.
Vetoquinol's large animal brands include: Marbocyl®, Sedalin®, Equistro®, Tolfine®, Pro Rumen and Locatim®.
The new team comprises:
The new sales team will be managed jointly by Hugh Gibson and Stuart Wade.
For further information or to make an appointment please contact your local Territory Manager direct or telephone 01280 825424
Dechra Veterinary Products has added to its Veterinary Essentials range of veterinary-licensed post-patent products with the launch of Fiprocat and Fiprodog, a fipronil spot-on solution for the treatment and prevention of on-animal flea infestations in cats and dogs.
Available in packs of 3 or 6 pipettes, Fiprocat and Fiprodog are only distributed through the veterinary channel. Dechra highlights the product's convenient self-standing pipette. which it says makes the process of applying the spot-on easier.
Dechra says it offers a wealth of client support material, and practice promotional support to go with the product.
Fiprocat and Fiprodog can be used as part of a treatment strategy for the control of Flea Allergy Dermatitis (FAD).
Rob Simpson at Dechra said: "Fipronil has been used in the treatment and prevention of on-animal flea infestations for many years and is one of the most commonly used treatments in practice. Fiprocat and Fiprodog join R.I.P Fleas Extra to offer a cost effective complete flea solution to tackle both on-animal and environmental flea infestations."
Petplan has launched a new look policy range to give pet owners more comprehensive cover and make it easier for them to understand the types of cover available.
Simon Masding, Petplan's Head of Sales and Partnerships said the refreshed policies will not only benefit the pet and their owner but the changes will also allow veterinary staff to explain the policies with a lot more clarity: "Since Petplan started 35 years ago the pet insurance market and vet industry has changed significantly, especially in the last few years. There are now over 250 policies in the market with varying benefits and levels of cover, which often confuses customers to a point where they think they're getting lifetime cover but they're instead trapped with a restrictive policy.
"The veterinary industry is also continually changing with advances in new technology and better diagnostics allowing the industry to save and treat more pets, which means our policies need to evolve with them."
To better understand these changing market dynamics, Petplan held focus groups with veterinary staff from across the UK and undertook extensive research with charities, breeders, customers and non-customers.
Apparently, the feedback showed that Petplan needed to communicate its range of policies more clearly, to shift away from the confusion created by other brands and meet the changing demands of the vet industry and pet owners better.
For this reason, Petplan says it has simplified its policy range, adding and increasing each policy's benefits, making a 12 month policy available for practices to offer, and developing easy-to-understand policy names.
Petplan's new look policies for both cats and dogs are:
Petplan says its Covered for Life policies, Petplan Ultimate and Petplan Classic, will continue to provide pet owners with the best cover in the market. However, the company recognises that these policies are not always suitable for people with older pets or a limited budget.
Simon said: "Petplan Essential, our 12 month policy, will also now be available for veterinary staff to offer to their customers. While our Covered for Life Ultimate and Classic will continue to be our leading policies and at the heart of what we do, it's better that a pet owner has some type of cover rather than nothing at all and Essential is a market leading 12 month policy."
Zeta Frasca, practice owner and vet at Kitten to Cat in Richmond London said: "These changes will not only make it clearer for the pet owner but it will also make it a lot easier for us as an industry to explain pet insurance to our clients, which is really important."
For more information about Petplan's new look policies visit www.petplan.co.uk, call their dedicated Vetline on 0800 3168 8900 or talk to your Petplan Business Developer.
The following table outlines each policy and its benefits:
BCF Technology has launched a competition in which the person who submits the best photograph with the theme of: All in a day's work - animal imaging, will win an iPad 2.
To enter the competition, you need to post your photographs, (and tell BCF a little about the story behind the images) at www.facebook.com/bcftechnology or email them to: info@bcftechnology.com
Jason Rogers, Marketing Manager at BCF said: "We wanted to create a fun way to show just how interesting and different each days work is when imaging animals. We have made the competition open to all that work with animal imaging including our staff, dealers and vets, vet nurses, animal contractors, etc from all over the world.
"It is great to see the BCF office in the States and our international dealers also promoting the competition in their own countries, making the competition truly international. Response to the competition has been fantastic - see our facebook page to some entries for yourself."
The closing date for the competition is 30th September 2011.
For more information, visit: www.bcftechnology.com
Eurovet Animal Health has announced that it is bringing a veterinary licensed vitamin K1 (phytomenadione) injectable preparation to the UK.
Eurovet says the new preparation, available from the wholesalers by Monday at the latest, will ensure that the previous supply problems of vitamin K1, will be overcome.
According to the company, the intravenous route is the only route to ensure a 100% bioavailability of vitamin K1 almost immediately and in a crisis situation is the best route of treatment. During anticoagulant poisoning, the coagulation factors are present in the body but are not functional. The faster vitamin K1 enters the blood flow, the quicker the coagulation function is restored.
Ruth Vernon, Technical Services Manager for Eurovet said: "We also plan to bring veterinary licenced vitamin K1 tablets to the UK market later in the year, allowing them to be ordered direct from veterinary wholesalers. The future continuity of supply represents a significant improvement on the current situation."
Anticoagulant rodenticide poisoning is the second most common query received by the VPIS. Alexander Campbell, Head of Service at VPIS, said: "The Veterinary Poisons Information Service receives well over 1000 telephone enquiries per annum from UK veterinary professionals seeking advice on how to manage potential and accidental exposures to anticoagulant rodenticides in a variety of animals - mainly pet dogs. Whilst most cases require basic assessment, first-aid and precautionary laboratory tests, an inevitable few develop serious intoxication and need long-term treatment. Vitamin K1 is a mainstay of therapy in these instances, and the availability of licensed veterinary-specific products in the UK is a major advance. Previously, preparations licensed for human use were often the only option when these could be sourced. Anything that ensures ready supply and facilitates speed of therapy for severe cases has to be welcomed."
There are over 500 anticoagulant rodent killing preparations available across Europe. They are available ready to use, as coated cereals, bait blocks, tracking powders, semolina formats or concentrates (which are reserved for professional use). Following cut backs in local council spending on pest control, the National Pest Technicians Association identified in a recent survey* that there is a 'worrying increase in poorly-managed DIY rodent control'.
*The NPTA National Rodent Survey 2009/2010
The company says its new design is modular, allowing veterinary practices to customise kennels to their requirements now, and then upgrade them and add components as their needs change over time.
Options include dimmable daylight lighting or Casco Pet’s DRC Lighting System with three modes: Daylight (white), Recovery (red), and Cleaning (blue UVA), built-in thermostatically controlled heat mats, an illuminated glass whiteboard for easy recording and viewing of patient notes, integrated IV stand and pump holders, an internal ceiling vent and ventilation kit and an integrated plug socket and USB port .
Matthew Bubear, CEO, Casco Pet, said: “Our new generation of WellKennels, which have been designed to meet the dynamic demands of modern veterinary practices, allow practitioners to elevate the care they provide today while ensuring sustained adaptability for the needs of tomorrow."
WellKennels are certified by the International Society of Feline Medicine and are part of FearFree’s Preferred Product Program, the global initiative dedicated to preventing and alleviating fear, anxiety and stress in pets.
The new WellKennels will be unveiled at the London Vet Show, ExCel London, 16-17 November, on Stand H35.
https://cascopet.com/uk/products-and-services/veterinary
Pfizer has released the results of its first Performance Index (formerly the Fort Dodge Index) which shows mildly improved trading conditions for the companion animal veterinary market in the first quarter of 2011.
Those aspects of veterinary business that showed an improvement in the first quarter of 2011 include: turnover growth (+0.8%, up from -0.1% in March 2010); client retention (+0.1%); the average number of visits per year (+ 0.17%); annual transaction value (+ 1.1%); average transaction value (+0.8% to £41.74); fee per product service (+0.2%) and products and services sold per visit (+0.6%).
Leveraged sales (typically pet-care products), which were down 2% (from 40% to 38%) in 2010, have increased 0.9% in the first quarter of 2011 to make up 39% of practice transactions.
Less positively and pointing to the need for veterinary practices to implement ongoing marketing initiatives, the number of new clients coming into practice is down (-0.4%) as is the number of active clients (-0.26%). Revenue from loyal clients (those that visit the practice for additional products and services, particularly vaccination and other preventative healthcare programmes) was static. Although flat growth is an improvement on previous reports, this is still a concern, as it is these clients who are the driver for revenue growth in many practices.
Pfizer Business Consultant, Simon Fowler said: "Although the figures are only very slightly improved this does mirror what we are seeing in practices that we visit. Practice turnover growth of 0.8%, while only small, is much better than any quarter in 2010. So we may be seeing the first green shoots of recovery, but there's still no room for complacency. Before we all breathe a collective sigh of relief, however, it should be remembered that as this is the first report for 2011 it is only an early picture, while a fuller story will be gleaned from the second report, which will show results from the first six months of the year.
"What is clear is the need for practices to market themselves in order to attract new clients, increase growth from active clients and increase client loyalty. VetSupport+ includes a range of marketing services to help practices in this respect. A practice has already achieved TV coverage via our Public Relations support service, while others are using PressRoom newsletter templates to keep potential and existing clients up to speed with the practice's news."
Further information about Pfizer's VetSupport+ service is available at www.vetsupportplus.co.uk.
Following a survey which indicates that veterinary surgeons are largely using unproven supplements to manage early-stage osteoarthritis, Hill's Pet Nutrition is calling upon vets to use evidence-based clinical nutrition to manage the condition.
The survey, which was carried out by independent market research firm Zyman Group, found that vets are more likely to give supplements than any other treatment in early stage osteoarthritis: 66% of cases receive supplements, 45% are given NSAIDs, and only 20% receive dietetic pet food.2
According to Hill's, its Prescription Diet j/d dry is clinically proven to improve mobility in osteoarthritic dogs in as little as 21 days; and 28 days in cats.3,4 Furthermore, the clinical study assigned to j/d is classified as Grade 1 level evidence - the highest grade reflecting the validity of clinical evidence. Another study has shown that Prescription Diet j/d also helps reduce NSAID dosage by up to 25 percent in dogs.5 This quality of evidence is, says Hill's, in contrast to many supplements.
John Innes, Professor of Small Animal Surgery at Liverpool, was involved in some of the early work on j/d: "Our results showed that the EPA in Hill's Prescription Diet j/d Canine pet food helped to reduce proteoglycan loss from cartilage. This would have beneficial effects in helping to preserve loss of cartilage. By preserving the cartilage, we can reduce pain in the long-term and ensure greater mobility for dogs with osteoarthritis."
Hill's has also announced that because a substantial majority of vets and nurses said that they felt that natural GACs have a positive effect in osteoarthritis1, its Prescription Diet j/d dry has been enriched with glucosamine and chondroitin sulphate.
Hill's j/d programme is now backed with money off vouchers, to improve client acceptance of veterinary recommendation. Clients who register on the website http://www.hillspetmobility.co.uk/,or http://www.hillspetmobility.ie/, will receive two £10 (or €10) money off e-coupons to use in clinic on their next purchases of j/d. They will also receive monthly e-mails containing information on how to take care of their pet with mobility problems, and help drive them back into the clinic for check-ups.
Veterinary surgeons who would like more information on the studies proving clinical efficacy, or score cards and trial guides for clients, should contact their Hill's Territory manager or call 0800 242438 or in ROI 1 800 626002. Clients can also fill in the scorecard online at www.hillspetmobility.co.uk or http://www.hillspetmobility.ie/
References
The European Commission has agreed with the BSAVA and BVA that controls must be maintained to keep the UK free from the tapeworm Echinococcus multilocularis, and adopted a regulation that will permit pre-movement treatment for dogs travelling to listed Member States (i.e. the UK, Ireland, Finland and Malta).
In June Defra announced that the UK's derogation from European pet travel rules, which allows additional protection for the UK against rabies, ticks and tapeworms, would end on 31 December 2011. The movement rules on rabies and ticks will now be harmonised with the rest of Europe.
However, due to the significant public health risk posed by Echinococcus multilocularis, the BVA and BSAVA (working with Defra, the Federation of Veterinarians of Europe [FVE] and colleagues in Veterinary Ireland) continued to lobby the European Commission for controls on tapeworms to be maintained.
The regulation will ensure that a dog must be treated by a veterinary surgeon 24 to 120 hours (1-5 days) before entering one of the listed countries.
The BVA and BSAVA say they made a scientific case for a treatment window of 24-48 hours, but accept that the Commission had to find a compromise that would assist pet owners travelling during national holidays.
Harvey Locke, President of the BVA said: "This has been a long process but the BVA and BSAVA put forward the strong scientific case for the UK to maintain tapeworm controls and we are delighted that the European Commission has adopted this resolution.
"In our role as guardians of public health, vets were deeply concerned that the removal of tapeworm controls would see the introduction of EM to the UK and Ireland.
"Although relatively benign in dogs, the resulting disease in humans - alveolar echinococcosis - is an invasive, cancer-like cystic stage of the parasite, and is invariably fatal if not treated.
"The next stage of our lobbying will be to ensure that Member States and MEPs from across Europe support the UK's case for the additional controls."
Andrew Ash, President of BSAVA said: "Echinococcus multilocularis is a significant public health threat and we have worked hard to ensure the European Commission understands the potential impact of allowing this zoonotic disease to enter our country.
"The BVA and BSAVA will continue to promote the best possible health and welfare advice for pet owners taking their animals abroad. Our advice to owners is to speak to a vet as early as possible to make sure pets are protected from all diseases and parasites encountered abroad."
Fabtek Solutions has announced the launch of Meditek, an activated carbon wound dressing which has been impregnated with silver to enhance its antibacterial qualities.
Joy Coutts from Fabtek Solutions said: "Meditek uses Zorflex which is a 100% pure activated carbon fibre. It has a huge surface area due to its microporous structure, and a permanent electrostatic charge that attracts bacteria towards it, where they are immobilised and retained. When removed from the substrate, the bacteria die, but the microscopic particulates of metallic silver accelerate the bacteria kill.
"Better still, Meditek carries no risk phases as it's non toxic and non invasive."
Joy added: "We are commercial members of the Vet Wound Library, an initiative designed to help promote modern wound care to veterinary professionals, it also means members can try our dressings for free."
According to Fabtek, Meditek has been tried and tested by vets and produced excellent results. The company's website also features some case studies which show the wound before and after the use of Meditek.
Dressings are available in 10cm x 10cm, and 15cm x 25cm sizes, which can be cut to fit. Prices start from £35 for a box of five.
For more information, see http://www.fabteksolutions.com/, email admin@fabteksolutions.com or call 07794094011.
The RCVS Charitable Trust has teamed up with the Foundation for Social Improvement (FSI) for the launch of the Great Big Small Charity Car Draw 2011.
The draw enables small charities, such as the RCVS Charitable Trust, to sell tickets to supporters which offer a chance of winning a brand new Fiat 500 1.2 Pop. Each ticket costs only £2, and the Trust will receive £1.90 for every ticket it sells.
Tickets can be bought securely online at http://trust.rcvs.org.uk/support-us/get-involved/win-a-fiat-500/ or directly from the Trust office on 020 7202 0721 or by emailing fundraising@rcvstrust.org.uk. Books of tickets are also available to sell to colleagues, friends and family. The deadline for buying tickets is September 16th 2011 with the draw taking place on 25th October 2011.
Here are a few examples of what reviewers have been saying about the Fiat 500:
"The Fiat 500 is both stylish and fun. The modest running costs complement the engaging handling. So, this nimble little city car can be enthusiastically thrown into corners and it should emerge grinning like a Cheshire Cat." Motoring.co.uk
"I love my Fiat 500 1.2 Pop from the moment I drove off in it. Great fun to drive on the motorway and in town for parking into slots others cannot!" What Car?
"It's absolutely fantastic. It drives like a dream. Everybody admires it." Fiat Forum
For further information on the car draw, please contact Fiona O'Regan on 020 7202 0743 or Rebecca Fellows on 020 7202 0721. Alternatively email fundraising@rcvstrust.org.uk.